Abstract |
Fibrosarcoma is an aggressive subtype of soft tissue sarcoma categorized in infantile/congenital-type and adult-type. Fibrosarcoma cells and its surrounding immune inflammatory infiltrates overexpress or induce the expression of fibroblast growth factor-2 (FGF-2) that have a crucial role in tumor progression and angiogenesis. The inflammation-associated long pentraxin 3 (PTX3) was found to reduce FGF-2-mediated angiogenesis, but its role on fibrosarcoma immune inflammatory infiltrate is still unknown. In this study, we have evaluated the PTX3 activity on immune infiltrating mast cells, macrophages and T-lymphocytes by immunohistochemistry on murine MC-TGS17-51 fibrosarcoma cells and on transgenic TgN(Tie2-hPTX3) mouse. In these fibrosarcoma models we found a reduced neovascularization and a significant decrease of inflammatory infiltrate. Indeed, we show that PTX3 reduces the level of complement 3 (C3) deposition reducing fibrosarcoma progression. In conclusion, we hypothesize that targeting fibrosarcoma microenvironment by FGF/FGFR inhibitors may improve treatment outcome.
|
Authors | Tiziana Annese, Roberto Ronca, Roberto Tamma, Arianna Giacomini, Simona Ruggieri, Elisabetta Grillo, Marco Presta, Domenico Ribatti |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 20
Issue 18
(Sep 17 2019)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 31533326
(Publication Type: Journal Article)
|
Chemical References |
- Serum Amyloid P-Component
- PTX3 protein
- C-Reactive Protein
|
Topics |
- Animals
- C-Reactive Protein
(genetics, metabolism)
- Cell Line, Tumor
- Disease Models, Animal
- Fibrosarcoma
(etiology, metabolism, pathology)
- Gene Expression
- Immunohistochemistry
- Immunomodulation
- Inflammation
(complications, genetics, immunology, metabolism)
- Male
- Mice
- Neovascularization, Pathologic
(genetics, metabolism)
- Serum Amyloid P-Component
(genetics, metabolism)
- Tumor Microenvironment
(genetics, immunology)
|